文献速递肝病

PNPLA3 rs738409 GG基因型与自身免疫性肝炎不良预后相关

The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis.
PubMed 文献 · Aliment Pharmacol Ther · 2020-04-22

本研究纳入239例自身免疫性肝炎患者,分析PNPLA3-rs738409等基因多态性对长期结局的影响。中位随访9.4年,11.7%患者死亡或需肝移植。PNPLA3-rs738409 GG变异与肝移植或死亡风险增加独立相关(HR 4.5),肝硬化也是强烈预测因素。

要点

  • PNPLA3-rs738409 GG基因型是自身免疫性肝炎患者肝移植或死亡的独立预测因素。
  • 肝硬化同样强烈预测不良结局(HR 9.24)。
  • 脂肪变、糖尿病和肥胖与结局无关。

核心结论

  • PNPLA3-rs738409 GG基因型可预测自身免疫性肝炎患者至肝移植或死亡的时间,有助于识别疾病进展高风险患者。

研究设计与样本

  • 纳入1983年至2018年间治疗的239例自身免疫性肝炎患者,从全血提取DNA并通过PCR分析基因多态性,215/239例(90%)有肝活检资料,通过病历回顾收集临床和实验室数据。

主要发现

  • 基线平均年龄42.1岁,女性占74.1%,中位随访9.4年(IQR 3.5-15.0),11.7%(n=28)患者死亡或需肝移植。
  • Kaplan-Meier分析显示PNPLA3-rs738409 GG变异患者更频繁达到主要终点(P=0.005)。
  • Cox回归分析中,PNPLA3-rs738409 GG(HR 4.5 [CI 1.48-13.72],P=0.008)和肝硬化(HR 9.24 [CI 2.11-40.44],P=0.003)是至肝移植或死亡的强烈预测因素。
  • 脂肪变、糖尿病和肥胖均与结局无关。

临床怎么用

  • 对自身免疫性肝炎患者可考虑检测PNPLA3-rs738409基因型,结合肝硬化状态识别高风险患者,加强监测和干预。

局限性

  • 研究为回顾性设计,样本量有限(239例),随访期间治疗变化可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fibrosis progression in autoimmune hepatitis can be attenuated by immunosuppressive treatment; however, some patients progress despite therapy. Single nucleotide polymorphisms (SNPs) such as PNPLA3-rs738409, TM6SF2-rs58542926 and MBOAT7-rs641738 are associated with non-alcoholic fatty liver disease and fibrosis progression, whereas a splice variant in HSD17B13-rs72613567:TA has been shown to be protective. AIM: To analyse the impact of different SNPs on the long-term outcome of patients with autoimmune hepatitis. METHODS: We included 239 patients into this study who had been treated between 1983 and 2018 for autoimmune hepatitis. Genomic DNA was isolated from whole blood and SNPs were determined by PCR analysis. Liver biopsies were available for 215/239 patients (90%). Clinical and laboratory patient data were assessed by chart review. RESULTS: Mean age at baseline was 42.1 years with 74.1% being female. The median follow-up was 9.4 years (IQR 3.5-15.0), 11.7% of the patients (n = 28) died or required liver transplantation. In the Kaplan-Meier analysis of the combined endpoint time to liver transplantation or death, we observed that patients with the PNPLA3-rs738409 GG variant met more frequently the primary endpoint (P = 0.005). In Cox regression analysis PNPLA3-rs738409 GG as well as liver cirrhosis were identified as strong predictors for time to liver transplantation or death (HR 4.5 [CI 1.48-13.72], P = 0.008 and HR 9.24 [CI 2.11-40.44], P = 0.003, respectively). Neither steatosis, diabetes mellitus nor obesity were associated with outcome. CONCLUSIONS: PNPLA3-rs738409 variant GG is a predictor for time to liver transplantation or death and may help to identify autoimmune hepatitis patients at risk for disease progression.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Mederacke YS, Kirstein MM, Großhennig A, et al. The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis. Aliment Pharmacol Ther. 2020. PMID: 32323349. doi:10.1111/apt.15722

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。